ENTRY       mmu05017                    Pathway
NAME        Spinocerebellar ataxia - Mus musculus (mouse)
DESCRIPTION The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.
CLASS       Human Diseases; Neurodegenerative disease
PATHWAY_MAP mmu05017  Spinocerebellar ataxia
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        22065  Trpc3; transient receptor potential cation channel, subfamily C, member 3 [KO:K04966]
            14816  Grm1; glutamate receptor, metabotropic 1 [KO:K04603]
            14682  Gnaq; guanine nucleotide binding protein, alpha q polypeptide [KO:K04634]
            18795  Plcb1; phospholipase C, beta 1 [KO:K05858] [EC:3.1.4.11]
            18797  Plcb3; phospholipase C, beta 3 [KO:K05858] [EC:3.1.4.11]
            18798  Plcb4; phospholipase C, beta 4 [KO:K05858] [EC:3.1.4.11]
            18796  Plcb2; phospholipase C, beta 2 [KO:K05858] [EC:3.1.4.11]
            18750  Prkca; protein kinase C, alpha [KO:K02677] [EC:2.7.11.13]
            18751  Prkcb; protein kinase C, beta [KO:K19662] [EC:2.7.11.13]
            18752  Prkcg; protein kinase C, gamma [KO:K19663] [EC:2.7.11.13]
            14799  Gria1; glutamate receptor, ionotropic, AMPA1 (alpha 1) [KO:K05197]
            14800  Gria2; glutamate receptor, ionotropic, AMPA2 (alpha 2) [KO:K05198]
            53623  Gria3; glutamate receptor, ionotropic, AMPA3 (alpha 3) [KO:K05199]
            12286  Cacna1a; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit [KO:K04344]
            16438  Itpr1; inositol 1,4,5-trisphosphate receptor 1 [KO:K04958]
            16439  Itpr2; inositol 1,4,5-triphosphate receptor 2 [KO:K04959]
            16440  Itpr3; inositol 1,4,5-triphosphate receptor 3 [KO:K04960]
            20239  Atxn2; ataxin 2 [KO:K23625]
            233871  Atxn2l; ataxin 2-like [KO:K23625]
            110616  Atxn3; ataxin 3 [KO:K11863] [EC:3.4.22.-]
            20190  Ryr1; ryanodine receptor 1, skeletal muscle [KO:K04961]
            18610  Pdyn; prodynorphin [KO:K15840]
            14810  Grin1; glutamate receptor, ionotropic, NMDA1 (zeta 1) [KO:K05208]
            14811  Grin2a; glutamate receptor, ionotropic, NMDA2A (epsilon 1) [KO:K05209]
            14812  Grin2b; glutamate receptor, ionotropic, NMDA2B (epsilon 2) [KO:K05210]
            14813  Grin2c; glutamate receptor, ionotropic, NMDA2C (epsilon 3) [KO:K05211]
            14814  Grin2d; glutamate receptor, ionotropic, NMDA2D (epsilon 4) [KO:K05212]
            242443  Grin3a; glutamate receptor ionotropic, NMDA3A [KO:K05213]
            170483  Grin3b; glutamate receptor, ionotropic, NMDA3B [KO:K05214]
            69597  Afg3l2; AFG3-like AAA ATPase 2 [KO:K08956] [EC:3.4.24.-]
            114896  Afg3l1; AFG3-like AAA ATPase 1 [KO:K08956] [EC:3.4.24.-]
            67013  Oma1; OMA1 zinc metallopeptidase [KO:K23010] [EC:3.4.24.-]
            74143  Opa1; OPA1, mitochondrial dynamin like GTPase [KO:K17079] [EC:3.6.5.5]
            14169  Fgf14; fibroblast growth factor 14 [KO:K23920]
            20743  Sptbn2; spectrin beta, non-erythrocytic 2 [KO:K23932]
            26443  Psma6; proteasome subunit alpha 6 [KO:K02730] [EC:3.4.25.1]
            19166  Psma2; proteasome subunit alpha 2 [KO:K02726] [EC:3.4.25.1]
            26441  Psma4; proteasome subunit alpha 4 [KO:K02728] [EC:3.4.25.1]
            26444  Psma7; proteasome subunit alpha 7 [KO:K02731] [EC:3.4.25.1]
            73677  Psma8; proteasome subunit alpha 8 [KO:K02731] [EC:3.4.25.1]
            26442  Psma5; proteasome subunit alpha 5 [KO:K02729] [EC:3.4.25.1]
            26440  Psma1; proteasome subunit alpha 1 [KO:K02725] [EC:3.4.25.1]
            19167  Psma3; proteasome subunit alpha 3 [KO:K02727] [EC:3.4.25.1]
            19175  Psmb6; proteasome (prosome, macropain) subunit, beta type 6 [KO:K02738] [EC:3.4.25.1]
            19177  Psmb7; proteasome (prosome, macropain) subunit, beta type 7 [KO:K02739] [EC:3.4.25.1]
            26446  Psmb3; proteasome (prosome, macropain) subunit, beta type 3 [KO:K02735] [EC:3.4.25.1]
            26445  Psmb2; proteasome (prosome, macropain) subunit, beta type 2 [KO:K02734] [EC:3.4.25.1]
            19173  Psmb5; proteasome (prosome, macropain) subunit, beta type 5 [KO:K02737] [EC:3.4.25.1]
            19170  Psmb1; proteasome (prosome, macropain) subunit, beta type 1 [KO:K02732] [EC:3.4.25.1]
            19172  Psmb4; proteasome (prosome, macropain) subunit, beta type 4 [KO:K02736] [EC:3.4.25.1]
            19181  Psmc2; proteasome (prosome, macropain) 26S subunit, ATPase 2 [KO:K03061]
            19179  Psmc1; protease (prosome, macropain) 26S subunit, ATPase 1 [KO:K03062]
            23996  Psmc4; proteasome (prosome, macropain) 26S subunit, ATPase, 4 [KO:K03063]
            67089  Psmc6; proteasome (prosome, macropain) 26S subunit, ATPase, 6 [KO:K03064]
            19182  Psmc3; proteasome (prosome, macropain) 26S subunit, ATPase 3 [KO:K03065]
            19184  Psmc5; protease (prosome, macropain) 26S subunit, ATPase 5 [KO:K03066]
            21762  Psmd2; proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 [KO:K03028]
            70247  Psmd1; proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 [KO:K03032]
            22123  Psmd3; proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 [KO:K03033]
            67151  Psmd9; proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 [KO:K06693]
            66997  Psmd12; proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 [KO:K03035]
            69077  Psmd11; proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 [KO:K03036]
            66413  Psmd6; proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 [KO:K03037]
            17463  Psmd7; proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 [KO:K03038]
            23997  Psmd13; proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 [KO:K03039]
            19185  Psmd4; proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 [KO:K03029]
            59029  Psmd14; proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 [KO:K03030]
            57296  Psmd8; proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 [KO:K03031]
            56436  Adrm1; adhesion regulating molecule 1 [KO:K06691]
            20422  Sem1; SEM1, 26S proteasome complex subunit [KO:K10881]
            78943  Ern1; endoplasmic reticulum (ER) to nucleus signalling 1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
            22030  Traf2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
            26408  Map3k5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
            26419  Mapk8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            26420  Mapk9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            26414  Mapk10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            20238  Atxn1; ataxin 1 [KO:K23616]
            52335  Atxn1l; ataxin 1-like [KO:K23616]
            81601  Kat5; K(lysine) acetyltransferase 5 [KO:K11304] [EC:2.3.1.48]
            19883  Rora; RAR-related orphan receptor alpha [KO:K08532]
            11937  Atp2a1; ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 [KO:K05853] [EC:7.2.2.10]
            53313  Atp2a3; ATPase, Ca++ transporting, ubiquitous [KO:K05853] [EC:7.2.2.10]
            11938  Atp2a2; ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 [KO:K05853] [EC:7.2.2.10]
            20513  Slc1a6; solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 [KO:K05617]
            71722  Cic; capicua transcriptional repressor [KO:K20225]
            80912  Pum1; pumilio RNA-binding family member 1 [KO:K17943]
            80913  Pum2; pumilio RNA-binding family member 2 [KO:K17943]
            21374  Tbp; TATA box binding protein [KO:K03120]
            237336  Tbpl1; TATA box binding protein-like 1 [KO:K03120]
            227606  Tbpl2; TATA box binding protein like 2 [KO:K03120]
            19664  Rbpj; recombination signal binding protein for immunoglobulin kappa J region [KO:K06053]
            19668  Rbpjl; recombination signal binding protein for immunoglobulin kappa J region-like [KO:K06053]
            20683  Sp1; trans-acting transcription factor 1 [KO:K04684]
            229906  Gtf2b; general transcription factor IIB [KO:K03124]
            18044  Nfya; nuclear transcription factor-Y alpha [KO:K08064]
            22433  Xbp1; X-box binding protein 1 [KO:K09027]
            17927  Myod1; myogenic differentiation 1 [KO:K09064]
            56717  Mtor; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            22241  Ulk1; unc-51 like kinase 1 [KO:K21357] [EC:2.7.11.1]
            29869  Ulk2; unc-51 like kinase 2 [KO:K08269] [EC:2.7.11.1]
            68118  Atg101; autophagy related 101 [KO:K19730]
            51897  Atg13; autophagy related 13 [KO:K08331]
            12421  Rb1cc1; RB1-inducible coiled-coil 1 [KO:K17589]
            228361  Ambra1; autophagy/beclin 1 regulator 1 [KO:K17985]
            56208  Becn1; beclin 1, autophagy related [KO:K08334]
            75669  Pik3r4; phosphoinositide-3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]
            100504663  Atg14; autophagy related 14 [KO:K17889]
            641340  Nrbf2; nuclear receptor binding factor 2 [KO:K21246]
            225326  Pik3c3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]
            329015  Atg2a; autophagy related 2A [KO:K17906]
            76559  Atg2b; autophagy related 2B [KO:K17906]
            52639  Wipi1; WD repeat domain, phosphoinositide interacting 1 [KO:K17908]
            74781  Wipi2; WD repeat domain, phosphoinositide interacting 2 [KO:K17908]
            16504  Kcnc3; potassium voltage gated channel, Shaw-related subfamily, member 3 [KO:K04889]
            56543  Kcnd3; potassium voltage-gated channel, Shal-related family, member 3 [KO:K04893]
            19699  Reln; reelin [KO:K06249] [EC:3.4.21.-]
            22359  Vldlr; very low density lipoprotein receptor [KO:K20053]
            13131  Dab1; disabled 1 [KO:K20054]
            18706  Pik3ca; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            18707  Pik3cd; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            74769  Pik3cb; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            18709  Pik3r2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            18708  Pik3r1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            18710  Pik3r3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            11651  Akt1; thymoma viral proto-oncogene 1 [KO:K04456] [EC:2.7.11.1]
            11652  Akt2; thymoma viral proto-oncogene 2 [KO:K04456] [EC:2.7.11.1]
            23797  Akt3; thymoma viral proto-oncogene 3 [KO:K04456] [EC:2.7.11.1]
            226153  Twnk; twinkle mtDNA helicase [KO:K17680] [EC:3.6.4.12]
            54138  Atxn10; ataxin 10 [KO:K19323]
            65115  Bean1; brain expressed, associated with Nedd4, 1 [KO:K19324]
            67134  Nop56; NOP56 ribonucleoprotein [KO:K14564]
COMPOUND    C00025  L-Glutamate
            C00076  Calcium cation
            C00165  Diacylglycerol
            C00238  Potassium cation
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01330  Sodium cation
            C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
REFERENCE   PMID:19890685
  AUTHORS   Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P
  TITLE     Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
  JOURNAL   Cerebellum 9:148-66 (2010)
            DOI:10.1007/s12311-009-0144-2
REFERENCE   PMID:16613893
  AUTHORS   Duenas AM, Goold R, Giunti P
  TITLE     Molecular pathogenesis of spinocerebellar ataxias.
  JOURNAL   Brain 129:1357-70 (2006)
            DOI:10.1093/brain/awl081
REFERENCE   PMID:27392710
  AUTHORS   Mark MD, Schwitalla JC, Groemmke M, Herlitze S
  TITLE     Keeping Our Calcium in Balance to Maintain Our Balance.
  JOURNAL   Biochem Biophys Res Commun 483:1040-1050 (2017)
            DOI:10.1016/j.bbrc.2016.07.020
REFERENCE   PMID:29253316
  AUTHORS   Egorova PA, Bezprozvanny IB
  TITLE     Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
  JOURNAL   FEBS J 285:3547-3565 (2018)
            DOI:10.1111/febs.14366
REFERENCE   PMID:28554312
  AUTHORS   Shimobayashi E, Kapfhammer JP
  TITLE     Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
  JOURNAL   Curr Neuropharmacol 16:151-159 (2018)
            DOI:10.2174/1570159X15666170529104000
REFERENCE   PMID:20480274
  AUTHORS   Kasumu A, Bezprozvanny I
  TITLE     Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
  JOURNAL   Cerebellum 11:630-9 (2012)
            DOI:10.1007/s12311-010-0182-9
REFERENCE   PMID:25846864
  AUTHORS   Egorova P, Popugaeva E, Bezprozvanny I
  TITLE     Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
  JOURNAL   Semin Cell Dev Biol 40:127-33 (2015)
            DOI:10.1016/j.semcdb.2015.03.010
REFERENCE   PMID:29777722
  AUTHORS   Hisatsune C, Hamada K, Mikoshiba K
  TITLE     Ca(2+) signaling and spinocerebellar ataxia.
  JOURNAL   Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)
            DOI:10.1016/j.bbamcr.2018.05.009
REFERENCE   PMID:27771899
  AUTHORS   Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH
  TITLE     Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.
  JOURNAL   Mol Neurobiol 54:6870-6884 (2017)
            DOI:10.1007/s12035-016-0205-8
REFERENCE   PMID:25653583
  AUTHORS   Brown SA, Loew LM
  TITLE     Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.
  JOURNAL   Front Neurosci 8:453 (2014)
            DOI:10.3389/fnins.2014.00453
REFERENCE   PMID:14748477
  AUTHORS   Inoue T
  TITLE     Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.
  JOURNAL   Keio J Med 52:244-9 (2003)
            DOI:10.2302/kjm.52.244
REFERENCE   PMID:18499672
  AUTHORS   Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N
  TITLE     Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.
  JOURNAL   J Biol Chem 283:19854-63 (2008)
            DOI:10.1074/jbc.M801492200
REFERENCE   PMID:26169942
  AUTHORS   Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS
  TITLE     Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
  JOURNAL   Brain 138:2537-52 (2015)
            DOI:10.1093/brain/awv195
REFERENCE   PMID:30910913
  AUTHORS   Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F
  TITLE     Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
  JOURNAL   J Med Genet 56:499-511 (2019)
            DOI:10.1136/jmedgenet-2018-105766
REFERENCE   PMID:30389403
  AUTHORS   Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F
  TITLE     Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
  JOURNAL   Neurobiol Dis 124:14-28 (2019)
            DOI:10.1016/j.nbd.2018.10.018
REFERENCE   PMID:25772041
  AUTHORS   Becker EBE
  TITLE     From Mice to Men: TRPC3 in Cerebellar Ataxia.
  JOURNAL   Cerebellum 16:877-879 (2017)
            DOI:10.1007/s12311-015-0663-y
REFERENCE   PMID:27857688
  AUTHORS   Hoxha E, Tempia F, Lippiello P, Miniaci MC
  TITLE     Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.
  JOURNAL   Front Synaptic Neurosci 8:35 (2016)
            DOI:10.3389/fnsyn.2016.00035
REFERENCE   PMID:23831029
  AUTHORS   Yan H, Pablo JL, Pitt GS
  TITLE     FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
  JOURNAL   Cell Rep 4:66-75 (2013)
            DOI:10.1016/j.celrep.2013.06.012
REFERENCE   PMID:26827887
  AUTHORS   Tada M, Nishizawa M, Onodera O
  TITLE     Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.
  JOURNAL   Neurochem Int 94:1-8 (2016)
            DOI:10.1016/j.neuint.2016.01.007
REFERENCE   PMID:20204399
  AUTHORS   Pietrobon D
  TITLE     CaV2.1 channelopathies.
  JOURNAL   Pflugers Arch 460:375-93 (2010)
            DOI:10.1007/s00424-010-0802-8
REFERENCE   PMID:15474358
  AUTHORS   Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T
  TITLE     Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
  JOURNAL   Neurobiol Dis 17:198-204 (2004)
            DOI:10.1016/j.nbd.2004.07.013
REFERENCE   PMID:12050113
  AUTHORS   Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H
  TITLE     ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.
  JOURNAL   Genes Dev 16:1345-55 (2002)
            DOI:10.1101/gad.992302
REFERENCE   PMID:24293103
  AUTHORS   Evers MM, Toonen LJ, van Roon-Mom WM
  TITLE     Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
  JOURNAL   Mol Neurobiol 49:1513-31 (2014)
            DOI:10.1007/s12035-013-8596-2
REFERENCE   PMID:28722507
  AUTHORS   Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC
  TITLE     Polyglutamine tracts regulate autophagy.
  JOURNAL   Autophagy 13:1613-1614 (2017)
            DOI:10.1080/15548627.2017.1336278
REFERENCE   PMID:31630678
  AUTHORS   Chen RH, Chen YH, Huang TY
  TITLE     Ubiquitin-mediated regulation of autophagy.
  JOURNAL   J Biomed Sci 26:80 (2019)
            DOI:10.1186/s12929-019-0569-y
REFERENCE   PMID:17110330
  AUTHORS   Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT
  TITLE     RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  JOURNAL   Cell 127:697-708 (2006)
            DOI:10.1016/j.cell.2006.09.036
REFERENCE   PMID:29526553
  AUTHORS   Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT
  TITLE     ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
  JOURNAL   Neuron 97:1235-1243.e5 (2018)
            DOI:10.1016/j.neuron.2018.02.013
REFERENCE   PMID:22526417
  AUTHORS   Jimenez G, Shvartsman SY, Paroush Z
  TITLE     The Capicua repressor--a general sensor of RTK signaling in development and disease.
  JOURNAL   J Cell Sci 125:1383-91 (2012)
            DOI:10.1242/jcs.092965
REFERENCE   PMID:29474920
  AUTHORS   Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY
  TITLE     A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.
  JOURNAL   Cell 172:924-936.e11 (2018)
            DOI:10.1016/j.cell.2018.02.006
REFERENCE   PMID:24218544
  AUTHORS   Irie T, Matsuzaki Y, Sekino Y, Hirai H
  TITLE     Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
  JOURNAL   J Physiol 592:229-47 (2014)
            DOI:10.1113/jphysiol.2013.264309
REFERENCE   PMID:26889478
  AUTHORS   Bushart DD, Murphy GG, Shakkottai VG
  TITLE     Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
  JOURNAL   Ann Transl Med 4:25 (2016)
            DOI:10.3978/j.issn.2305-5839.2016.01.06
REFERENCE   PMID:31293010
  AUTHORS   Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ
  TITLE     Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.
  JOURNAL   Hum Mutat 40:2088-2107 (2019)
            DOI:10.1002/humu.23865
REFERENCE   PMID:25854634
  AUTHORS   Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS
  TITLE     Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
  JOURNAL   Cell Mol Life Sci 72:3387-99 (2015)
            DOI:10.1007/s00018-015-1894-2
REFERENCE   PMID:31145571
  AUTHORS   Matilla-Duenas A, Volpini V
  TITLE     Spinocerebellar Ataxia Type 37
  JOURNAL   (1993)
REFERENCE   PMID:29939198
  AUTHORS   Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A
  TITLE     Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
  JOURNAL   Brain 141:1981-1997 (2018)
            DOI:10.1093/brain/awy137
REFERENCE   PMID:31721251
  AUTHORS   Swinnen B, Robberecht W, Van Den Bosch L
  TITLE     RNA toxicity in non-coding repeat expansion disorders.
  JOURNAL   EMBO J e101112 (2019)
            DOI:10.15252/embj.2018101112
REFERENCE   PMID:31755042
  AUTHORS   Ishikawa K, Nagai Y
  TITLE     Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).
  JOURNAL   Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)
            DOI:10.1007/s13311-019-00804-6
REFERENCE   PMID:23607545
  AUTHORS   Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K
  TITLE     Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.
  JOURNAL   Neuropathology 33:600-11 (2013)
            DOI:10.1111/neup.12032
REFERENCE   PMID:21683323
  AUTHORS   Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, Habu T, Liu W, Okuda H, Koizumi A
  TITLE     Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
  JOURNAL   Am J Hum Genet 89:121-30 (2011)
            DOI:10.1016/j.ajhg.2011.05.015
REL_PATHWAY mmu03050  Proteasome
            mmu04020  Calcium signaling pathway
            mmu04140  Autophagy - animal
            mmu04141  Protein processing in endoplasmic reticulum
            mmu04210  Apoptosis
            mmu04724  Glutamatergic synapse
            mmu04730  Long-term depression
KO_PATHWAY  ko05017
///
